Monument Mining Limited (MMY)
TSX Venture Exchange · Canada · prices in CAD · close of 22 Oct 2026
Key indicators
| Last close | CAD 0.730 |
|---|---|
| 52-week range | 0.710 – 1.550 |
| Return, 1 month / 3 months | −29.1% / −3.9% |
| Return, 1 year / 3 years | −26.5% / +470.8% |
| Trend | Below its 200-day average |
| RSI (14) | 32 |
| Volatility (1 year) | 63.4% |
| Worst drawdown (1 year) | -52.0% |
| Average daily value traded | 0.33M CAD |
| Dividend yield | 2.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Monument Mining Limited is a gold mining company based in Vancouver, Canada, with its principal mining operations in Malaysia. The company explores for, develops and produces gold, and its main asset is the Selinsing gold mine in Pahang, where it operates an open pit mine and processing plant. Monument Mining also holds exploration properties in Malaysia and Australia, and its customers are the buyers of gold doré and concentrate produced at its mines.
On this site Monument Mining Limited appears as a stock on the TSX Venture Exchange (Canada), code MMY, with prices in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Monument Mining Limited (MMY) trades on the TSX Venture Exchange in Canada. It last closed at CAD 0.730 on 22 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 530 of 1,501 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 26.5% and over the last three months it fell 3.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on TSX Venture Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 48 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -23.4% | ||
| From 52-week high | -51.3% | ||
| Momentum | 57 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -3.9% | ||
| 6-month return | -15.1% | ||
| 12-month return, skipping the last month | 3.7% | ||
| Stability (higher is calmer) | 71 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 63.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -52.0% | ||
| Liquidity | 94 · Strong | Trades actively. | |
| Average daily value traded | 0.33M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 16 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.7% | ||
| Years with dividends | 1 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Income: Dividend is small or irregular.
Returns
| 1 week | −5.2% |
|---|---|
| 1 month | −29.1% |
| 3 months | −3.9% |
| 6 months | −15.1% |
| 1 year | −26.5% |
| 3 years | +470.8% |
| 5 years | +430.1% |
Signals
| 50-day / 200-day average | 0.924 / 0.953 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.040 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Jan 2026 | CAD 0.0200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on TSX Venture Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.